The Top 5 Analyst Questions From Regal Rexnord's Q2 Earnings Call

Regal Rexnord’s second quarter saw results that met Wall Street revenue expectations, with adjusted earnings per share slightly ahead of consensus. Management attributed this performance to resilience in the company’s industrial and automation segments, despite lingering headwinds in metals, mining, and rare earth magnet availability. CEO Louis Pinkham highlighted that temporary delays in higher-margin shipments, particularly in medical and defense, were offset by strong demand in residential and commercial HVAC and aerospace. The team emphasized ongoing efforts to neutralize tariff impacts and maintain stable operating margins, while acknowledging that project timing and supply constraints weighed on some segments.

Is now the time to buy RRX? Find out in our full research report (it’s free).

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Regal Rexnord’s Q2 Earnings Call

• Michael Patrick Halloran (Baird) pressed for clarity on end market recovery expectations. CEO Louis Pinkham explained that industrial demand remains at trough levels, but growing backlogs in IPS and AMC should drive gradual improvement.
• Kyle David Menges (Citigroup) asked about the sustainability of backlog-driven growth in IPS and AMC, and its impact on margins. Pinkham noted that systems and data center sales are mix accretive, supporting average or better segment margins.
• Jeffrey David Hammond (KeyBanc Capital Markets) sought quantification of rare earth impacts and cost recovery. CFO Rob Rehard cited a $6 million margin hit in Q2, with most losses expected to be recouped by year-end.
• Julian C.H. Mitchell (Barclays) inquired about visibility into medical market inventory and automation demand. Management responded that medical channel inventories are improving and automation backlog is up double digits, supporting confidence in a margin step-up.
• Nigel Edward Coe (Wolfe Research) questioned the range in AMC margin guidance and rare earth sourcing progress. Rehard explained the wider margin range reflects ongoing supply risk, but recent actions have stabilized magnet supply for commercial applications.

Catalysts in Upcoming Quarters

In future quarters, our analyst team will closely watch (1) the ramp and monetization of large data center orders in AMC, (2) the pace of backlog conversion in IPS and its impact on sales growth, and (3) the successful mitigation of rare earth supply and tariff challenges. Execution on remaining cost synergies and evidence of margin recovery in the second half will also be key markers of progress.

Regal Rexnord currently trades at $137.95, down from $145.28 just before the earnings. Is there an opportunity in the stock?The answer lies in our full research report (it’s free).

Our Favorite Stocks Right Now

When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.

Don’t let fear keep you from great opportunities and take a look at Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.